1. Home
  2. SNEX vs APGE Comparison

SNEX vs APGE Comparison

Compare SNEX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$77.76

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$79.70

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNEX
APGE
Founded
1924
2022
Country
United States
United States
Employees
5400
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.7B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
SNEX
APGE
Price
$77.76
$79.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$81.33
$109.25
AVG Volume (30 Days)
512.3K
1.0M
Earning Date
05-06-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.50
N/A
Revenue
$132,378,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.69
N/A
P/E Ratio
$31.11
N/A
Revenue Growth
32.53
N/A
52 Week Low
$65.58
$26.20
52 Week High
$132.57
$85.04

Technical Indicators

Market Signals
Indicator
SNEX
APGE
Relative Strength Index (RSI) 27.64 60.14
Support Level N/A $73.06
Resistance Level $97.49 $81.04
Average True Range (ATR) 3.83 4.62
MACD -3.43 0.96
Stochastic Oscillator 21.15 73.26

Price Performance

Historical Comparison
SNEX
APGE

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: